It contains the same active ingredient as the Wegovy injection, is taken once daily as a tablet on an empty stomach, and is prescription-only, offered after clinical assessment against BMI-based eligibility as an adjunct to a reduced-calorie diet and increased physical activity
Stimulates lipolysis (fat breakdown): AOD 9604, in particular, is noted for its ability to stimulate the breakdown of stored fat
The FDA still has to decide, but historically they follow what the advisory committees recommend
Yes, abdominal pain is a recognised and common side effect of Ozempic (semaglutide), a GLP-1 receptor agonist used to treat type 2 diabetes in the UK
Basic Clin Pharmacol Toxicolol (2015) 116:2516
However, if semaglutide causes nausea or vomiting, it may reduce the absorption of oral contraceptives in some casesthough this is uncommon